Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood

被引：3
|
作者：
Tobler, LH [1 ]
Dockter, J
Stramer, SL
Kleinman, SH
Todd, D
Giachetti, C
Busch, MP
机构：
[1] Blood Ctr Pacific, San Francisco, CA USA
[2] GenProbe Inc, San Diego, CA USA
[3] Amer Red Cross, Natl Confirmatory Testing Lab, Gaithersburg, MD USA
[4] Westat Corp, Rockville, MD USA
[5] Univ British Columbia, Victoria, BC, Canada
[6] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
来源：
TRANSFUSION | 2002年 / 42卷 / 11期
关键词：
D O I：
10.1046/j.1537-2995.2002.00266.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1525 / 1527
页数：3
相关论文
共 50 条
  • [41] Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load
    Katsoulidou, A.
    Moschidis, Z.
    Sypsa, V.
    Chini, M.
    Papatheodoridis, G. V.
    Tassopoulos, N. C.
    Mimidis, K.
    Karafoulidou, A.
    Hatzakis, A.
    VOX SANGUINIS, 2007, 92 (01) : 8 - 14
  • [42] NAT cross-supplemental role assessment of the COBAS AmpliScreen and Procleix TMA HIV-1 and HCV assays using initial reactive donor specimens
    Caglioti, S
    Robertson, G
    Winkelman, V
    Brodsky, J
    McAuley, J
    Houghton, D
    Stramer, S
    Busch, MP
    TRANSFUSION, 2004, 44 (09) : 87A - 88A
  • [43] HCV viremia among HIV-1 and HCV co-infected women
    Nikolopoulou, G
    Nowicki, MJ
    Kramer, F
    Stek, A
    Fassett, M
    Rother, C
    Chan, L
    Kovacs, A
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1223 - 1223
  • [44] Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease
    Yoo, TW
    Donfield, S
    Lail, A
    Lynn, HS
    Daar, ES
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (01): : 4 - 10
  • [45] Significant closure of the HIV-1 detection window with the TMA HIV-1/HCV assay
    Kolk, D
    Hotaling, S
    Baker, D
    Mimms, L
    Giachetti, C
    TRANSFUSION, 1999, 39 (10) : 70S - 70S
  • [46] Significant closure of the HCV detection window with the TMA HIV-1/HCV assay
    Hotaling, S
    Kolk, D
    Baker, D
    Mimms, L
    Giachetti, C
    TRANSFUSION, 1999, 39 (10) : 67S - 67S
  • [47] Early antiretroviral therapy: an immunotherapy to combat HCV in HIV-1/HCV coinfection
    Kim, Arthur Y.
    FUTURE VIROLOGY, 2007, 2 (04) : 319 - 323
  • [48] Sensitivity of Chiron ProcleixTM HIV1/HCV assay on a population at high risk for HIV-1 and/or HCV infection
    中国输血杂志, 2001, (S1) : 401 - 401
  • [49] Evaluation of the PROCLEIX® ULTRIO® on the PROCILEIX® TIGRIS® system for HBV/HCV/HIV blood screening in Taiwan
    Li, L.
    Chen, M-H
    Hung, C-S
    Lin, H-J
    Tsai, Su-J L.
    Lin, K-S
    TRANSFUSION, 2008, 48 (02) : 97A - 97A
  • [50] Benefits of the test CHIRON PROCLEIX ULTRIO ASSAY HCV/HIV/HBB in the improvement of blood safety
    Morelli, F.
    de Felice, C.
    Macr, M. M.
    VOX SANGUINIS, 2006, 91 : 85 - 86
12345